Literature DB >> 32777070

Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age-specific mouse model.

Nitza Vara1, Yuqing Liu2, Yan Yan1, Shelly Y Lensing1,3, Natalia Colorado1, Delli Robinson1, Jingliao Zhang1, Xin Zhang1,4, Erich A Peterson1, Nicholas J Baltz1, Daohong Zhou1,4, Alice Bertaina5, Donald J Johann1, Peter D Emanuel1,6, Y Lucy Liu1,5.   

Abstract

It is not clear whether disrupted age-specific hematopoiesis contributes to the complex manifestations in leukemia patients who carry identical mutations, particularly in pediatric and adult patients with similar clinical characteristics. By studying a dual-age-specific mouse model, we demonstrate that (1) loss of Pten during the fetal-to-adult hematopoiesis switch (hematopoiesis switch) causes sustained fetal hematopoiesis, resulting in death in juvenile leukemia; (2) myeloid-biased hematopoiesis in juvenile mice is associated with the sustained fetal properties of hematopoietic stem cells (HSCs); (3) the age specificity of juvenile myelomonocytic leukemia depends on the copy number of Pten and Nf1; (4) single-allelic Pten deletion during the hematopoiesis switch causes constitutive activation of MAPK in juvenile mice with Nf1 loss of heterozygosity (LOH); and (5) Nf1 LOH causes monocytosis in juvenile mice with Pten haploinsufficiency but does not cause lethality until adulthood. Our data suggest that 1 copy of Pten is sufficient to maintain an intact negative-feedback loop of the Akt pathway and HSC function in reconstitution, despite MAPK being constitutively activated in juvenile Pten+/ΔNf1LOH mice. However, 2 copies of Pten are required to maintain the integrity of the MAPK pathway in juvenile mice with Nf1 haploinsufficiency. Our data indicate that previous investigations of Pten function in wild-type mice may not reflect the impact of Pten loss in mice with Nf1 mutations or other genetic defects. We provide a proof of concept that disassociated age-specific hematopoiesis contributes to leukemogenesis and pediatric demise.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 32777070      PMCID: PMC7422126          DOI: 10.1182/bloodadvances.2020002326

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  42 in total

Review 1.  JMML genomics and decisions.

Authors:  Charlotte M Niemeyer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential.

Authors:  Momoko Yoshimoto; Encarnacion Montecino-Rodriguez; Michael J Ferkowicz; Prashanth Porayette; W Christopher Shelley; Simon J Conway; Kenneth Dorshkind; Mervin C Yoder
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-05       Impact factor: 11.205

3.  LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia.

Authors:  Hetty H Helsmoortel; Silvia Bresolin; Tim Lammens; Hélène Cavé; Peter Noellke; Aurélie Caye; Farzaneh Ghazavi; Andrica de Vries; Henrik Hasle; Veerle Labarque; Riccardo Masetti; Jan Stary; Marry M van den Heuvel-Eibrink; Jan Philippé; Nadine Van Roy; Yves Benoit; Frank Speleman; Charlotte Niemeyer; Christian Flotho; Giuseppe Basso; Geertruy Te Kronnie; Pieter Van Vlierberghe; Barbara De Moerloose
Journal:  Blood       Date:  2015-12-28       Impact factor: 22.113

4.  Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents.

Authors:  Ana Alfonso; Guillermo Montalban-Bravo; Koichi Takahashi; Elias J Jabbour; Tapan Kadia; Farhad Ravandi; Jorge Cortes; Zeev Estrov; Gautam Borthakur; Naveen Pemmaraju; Marina Konopleva; Carlos Bueso-Ramos; Sherry Pierce; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Am J Hematol       Date:  2017-05-26       Impact factor: 10.047

5.  Reference values of blood cell counts in the first days of life.

Authors:  Giovanni Melioli; Francesco Maria Risso; Andrea Sannia; Giovanni Serra; Roberto Bologna; Michele Mussap; Salvatore Mangraviti; Patrizia Fortini; Fabio Facco; Giorgio Reggiardo; Giuseppe Buonocore; Giovanni Corsello; Vassilios Fanos; Antonello Del Vecchio; Claudio Fabris; Diego Gazzolo
Journal:  Front Biosci (Elite Ed)       Date:  2011-06-01

6.  Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.

Authors:  G Bollag; D W Clapp; S Shih; F Adler; Y Y Zhang; P Thompson; B J Lange; M H Freedman; F McCormick; T Jacks; K Shannon
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

7.  Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogene.

Authors:  Courteney K Lai; Yeonsook Moon; Florian Kuchenbauer; Daniel T Starzcynowski; Bob Argiropoulos; Eric Yung; Philip Beer; Adrian Schwarzer; Amit Sharma; Gyeongsin Park; Malina Leung; Grace Lin; Sarah Vollett; Stephen Fung; Connie J Eaves; Aly Karsan; Andrew P Weng; R Keith Humphries; Michael Heuser
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

8.  Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors.

Authors:  K Geissler; E Jäger; A Barna; T Alendar; E Ljubuncic; T Sliwa; P Valent
Journal:  Leukemia       Date:  2016-08-18       Impact factor: 11.528

9.  Distinct Molecular Signature of Murine Fetal Liver and Adult Hematopoietic Stem Cells Identify Novel Regulators of Hematopoietic Stem Cell Function.

Authors:  Javed K Manesia; Monica Franch; Daniel Tabas-Madrid; Ruben Nogales-Cadenas; Thomas Vanwelden; Elisa Van Den Bosch; Zhuofei Xu; Alberto Pascual-Montano; Satish Khurana; Catherine M Verfaillie
Journal:  Stem Cells Dev       Date:  2017-02-13       Impact factor: 3.272

10.  The genomic landscape of juvenile myelomonocytic leukemia.

Authors:  Elliot Stieglitz; Amaro N Taylor-Weiner; Tiffany Y Chang; Laura C Gelston; Yong-Dong Wang; Tali Mazor; Emilio Esquivel; Ariel Yu; Sara Seepo; Scott Olsen; Mara Rosenberg; Sophie L Archambeault; Ghada Abusin; Kyle Beckman; Patrick A Brown; Michael Briones; Benjamin Carcamo; Todd Cooper; Gary V Dahl; Peter D Emanuel; Mark N Fluchel; Rakesh K Goyal; Robert J Hayashi; Johann Hitzler; Christopher Hugge; Y Lucy Liu; Yoav H Messinger; Donald H Mahoney; Philip Monteleone; Eneida R Nemecek; Philip A Roehrs; Reuven J Schore; Kimo C Stine; Clifford M Takemoto; Jeffrey A Toretsky; Joseph F Costello; Adam B Olshen; Chip Stewart; Yongjin Li; Jing Ma; Robert B Gerbing; Todd A Alonzo; Gad Getz; Tanja Gruber; Todd Golub; Kimberly Stegmaier; Mignon L Loh
Journal:  Nat Genet       Date:  2015-10-12       Impact factor: 38.330

View more
  1 in total

Review 1.  Advances in molecular characterization of myeloid proliferations associated with Down syndrome.

Authors:  Jixia Li; Maggie L Kalev-Zylinska
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.